CLIP: Soaring insulin prices prompt HealthPartners, Geisinger to take action

ACHP plans are taking action to relieve consumer costs as prices for insulin soar. At HealthPartners, the members who are hardest hit by rising insulin prices are those in high-deductible health plans. In response, HealthPartners  has launched a program where members will pay the generic copay instead of the brand copay if that brand drug becomes cheaper than the generic version. HealthPartners then reimburses the pharmacy the brand cost. At Geisinger Health Plan, Medicare enrollees are the ones who have the most trouble paying for their insulin. This has prompted the health plan to consider adding a sixth, zero-dollar tier to its Part D formulary where it would put insulin and select other drugs.